Valneva is a fully integrated, commercial stage biotech company focused on developing innovative life-saving vaccines. Valneva generates strong revenues with its commercial products and at the same time, invests in research and development of promising product candidates. Valneva’s mission is to protect the lives of people around the world through innovative vaccines against infectious diseases.
R&D:Valneva Austria is focused on pre-clinical and clinical development of vaccines. In addition, labs for quality control of Valneva's approved vaccines are located in Vienna. Since 2016, Valneva Austria GmbH distributes its own vaccines as well as third party products in Austria.
Campus Vienna Biocenter 3
1030 Vienna
Vienna
Contact: Teresa Pinzolits
Telephone: +43 (1) 20620
Email: communications@valneva.com
Website